New Jersey S 803: Requires health care practitioners to inform patients of addiction potential of controlled dangerous substances prior to issuing prescription.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2016-01-12)

State: New Jersey · Session: 217 · Bill: S 803

Subjects: DRUG ABUSE, HEALTH PROF, PHARMACEUTIC

Sponsors: Vitale, Joseph F., Weinberg, Loretta, Addiego, Dawn Marie, Allen, Diane B., Codey, Richard J., Gordon, Robert M., Greenstein, Linda R., Lesniak, Raymond J., Madden, Fred H., Rice, Ronald L., Singer, Robert W., Whelan, Jim

View New Jersey S 803 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.